Header Logo

Connection

Yang Xiang to Female

This is a "connection" page, showing publications Yang Xiang has written about Female.
Connection Strength

1.154
  1. Zhang Y, Guan Y, Xiao X, Xu S, Zhu S, Cao D, Yu M, Peng P, Wang J, Wang Y, Yin R, Guo J, Gao W, Li P, Bai J, Gong Y, Xia X, Yi X, Yang L, Xiang Y. Circulating tumor DNA detection improves relapse prediction in epithelial ovarian cancer. BMC Cancer. 2024 Dec 22; 24(1):1565.
    View in: PubMed
    Score: 0.049
  2. He SQ, Liu GY, Yu YH, Wang L, Zhang GY, Peng DS, Bei WX, Chen CL, Lv SH, Zhao ZY, Huang Y, Xiang YQ. Efficacy of local-regional radiotherapy in de novo metastatic nasopharyngeal carcinoma patients receiving chemo-immunotherapy: A multicenter, propensity score matching study. Radiother Oncol. 2025 02; 203:110687.
    View in: PubMed
    Score: 0.048
  3. He SQ, Liu GY, Yu YH, Wang L, Zhang GY, Peng DS, Bei WX, Chen CL, Lv SH, Zhao ZY, Huang Y, Xiang YQ. Establishing M1 subdivision for de novo nasopharyngeal carcinoma patients receiving immuno-chemotherapy: A multicenter, retrospective cohort study. Oral Oncol. 2024 Dec; 159:107074.
    View in: PubMed
    Score: 0.048
  4. Xiang Y, Pan BH, Zhang J, Chen JQ, Fang H, Wang Q, Li LH, Chen TS, Chen JX, Li C, Zheng XF, Zhu SH. Suppression of overactivated immunity in the early stage is the key to improve the prognosis in severe burns. Front Immunol. 2024; 15:1455899.
    View in: PubMed
    Score: 0.048
  5. Liu GY, Ye YF, Jiang YF, Chen GJ, Xia WX, Huang YS, Gao TS, Liu YM, Hou YT, Li JF, Liu JH, Lu N, Chen CL, Ke LR, Liang H, Bei WX, Li WZ, Dong SH, Liu Q, Xie C, Yao HR, Xiang YQ. Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trial. BMJ. 2024 06 19; 385:e077890.
    View in: PubMed
    Score: 0.047
  6. Jiang F, Mao M, Jiang S, Jiao Y, Cao D, Xiang Y. PD-1 and TIGIT coexpressing CD8?+?CD103?+?tissue-resident memory cells in endometrial cancer as potential targets for immunotherapy. Int Immunopharmacol. 2024 Jan 25; 127:111381.
    View in: PubMed
    Score: 0.045
  7. Zhang Z, Cao Z, Wang J, Li Z, Wang T, Xiang Y. Serum protein N-glycome patterns reveal alterations associated with endometrial cancer and its phenotypes of differentiation. Front Endocrinol (Lausanne). 2023; 14:1157487.
    View in: PubMed
    Score: 0.044
  8. Zhu S, Zhang C, Cao D, Bai J, Yu S, Chen J, Wang J, Ren T, Yang J, Yu M, Xiao X, Gong Y, Guan Y, Li P, Yue Y, Yin R, Wang Y, An R, Lou G, Yuan J, Zhang G, Xia X, Yang L, Xiang Y. Genomic and TCR profiling data reveal the distinct molecular traits in epithelial ovarian cancer histotypes. Oncogene. 2022 05; 41(22):3093-3103.
    View in: PubMed
    Score: 0.040
  9. Liu GY, Li WZ, Wang DS, Liang H, Lv X, Ye YF, Zhao C, Ke LR, Lv SH, Lu N, Bei WX, Cai ZC, Chen X, Liang CX, Guo X, Xia WX, Xiang YQ. Effect of Capecitabine Maintenance Therapy Plus Best Supportive Care vs Best Supportive Care Alone on Progression-Free Survival Among Patients With Newly Diagnosed Metastatic Nasopharyngeal Carcinoma Who Had Received Induction Chemotherapy: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2022 04 01; 8(4):553-561.
    View in: PubMed
    Score: 0.040
  10. Wang D, Jia C, Cheng H, Cao D, Shen K, Yang J, Xiang Y. Analysis of Outcomes and Prognostic Factors after Fertility-Sparing Surgery in Patients with Early Stage Juvenile Granulosa Cell Tumor of the Ovary: Experience from a Tertiary Center. J Pediatr Adolesc Gynecol. 2022 Aug; 35(4):486-491.
    View in: PubMed
    Score: 0.039
  11. Cheng H, Zong L, Kong Y, Wang X, Gu Y, Cang W, Zhao J, Wan X, Yang J, Xiang Y. Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial. Lancet Oncol. 2021 11; 22(11):1609-1617.
    View in: PubMed
    Score: 0.039
  12. Xia WX, Lv X, Liang H, Liu GY, Sun R, Zeng Q, Li SW, Mo HY, Han F, Luo DH, Liu Q, Shi MY, Ye YF, Yang J, Ke LR, Qiang MY, Qiu WZ, Yu YH, Liu KY, Huang XJ, Li WZ, Lv SH, Cai ZC, Miao JJ, Guo L, Chen MY, Cao KJ, Wang L, Zhao C, Huang PY, Chen QY, Hua YJ, Tang LQ, Qian CN, Mai HQ, Guo X, Xiang YQ. A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer. Clin Cancer Res. 2021 08 01; 27(15):4186-4194.
    View in: PubMed
    Score: 0.038
  13. Fan F, Yang C, Zhu X, Liu Z, Liu H, Li J, Jiang R, Zhang Y, Bu X, Wang Y, Wang Q, Xiang Y. Association between infectious burden and cerebral microbleeds: a pilot cross-sectional study. Ann Clin Transl Neurol. 2021 02; 8(2):395-405.
    View in: PubMed
    Score: 0.037
  14. Li WZ, Lv SH, Liu GY, Liang H, Guo X, Lv X, Liu KY, Qiang MY, Chen X, Gu SZ, Xie CQ, Xia WX, Xiang YQ. Development of a Prognostic Model to Identify the Suitable Definitive Radiation Therapy Candidates in de Novo Metastatic Nasopharyngeal Carcinoma: A Real-World Study. Int J Radiat Oncol Biol Phys. 2021 01 01; 109(1):120-130.
    View in: PubMed
    Score: 0.036
  15. Xiang Y, Bu XL, Liu YH, Zhu C, Shen LL, Jiao SS, Zhu XY, Giunta B, Tan J, Song WH, Zhou HD, Zhou XF, Wang YJ. Physiological amyloid-beta clearance in the periphery and its therapeutic potential for Alzheimer's disease. Acta Neuropathol. 2015 Oct; 130(4):487-99.
    View in: PubMed
    Score: 0.025
  16. Xiang Y, Chen JH, Cai D, Ma BJ. Effect of Lidan Granule on bile lithogenesis in patients with choledocholithiasis combined with cholecystolithiasis. Chin J Integr Med. 2008 Jun; 14(2):142-4.
    View in: PubMed
    Score: 0.016
  17. Chen L, Hu L, Liu X, Wang X, Tan C, Chen M, Yin X, Yang W, Yang Z, Xiang Y, Xiao Y, Xiang L, Li X, Li J, Zhang W, Wang X, Lin C, Zhang Y, Gou W, Jiang Y, Yu T, Yang R, Li SC, Ran Q, Li Z. Single-cell profiling of ANKRD26 thrombocytopenia reveals progenitor expansion and polyploid apoptosis via JUNB-p21. Blood. 2026 Apr 23; 147(17):1984-1998.
    View in: PubMed
    Score: 0.013
  18. Han F, Lv X, Zhou YJ, He Q, Guo Y, Xiang YQ, Shu XL, Pan SM, Qu SH, Zhang P, Jiang Y, Xu MJ, Lei KJ, Qu S, Wang XH, Jin YS, Zhao B, Dai R, Wang FH, Xu RH. Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial. Med. 2026 Apr 10; 7(4):101029.
    View in: PubMed
    Score: 0.013
  19. Cao X, Zhou JY, Huang HY, Guo L, Huang YY, Qiu WZ, Lin ZC, Cao KJ, Mo HY, Li XM, Li ZH, Han F, He YX, Liu YM, Bai YR, Wu SX, Ke LR, Chen X, Liang CX, Luo ZY, Xia Y, Deng Y, Miao JJ, Xia WX, Liang H, Zhao C, Xiang YQ, Guo X, Lv X. Final survival analysis of induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by concurrent chemoradiotherapy in nasopharyngeal carcinoma: a multicenter, randomized, phase 3 trial. Nat Commun. 2026 02 10; 17(1).
    View in: PubMed
    Score: 0.013
  20. Liu Q, Wei JN, Zhou JY, Zhang CR, Ke LR, Lu N, Deng Y, Kuang YW, Hua YC, Wang MW, Gong J, Dong SH, Wu L, Lv X, Xiang YQ, Guo X, Xia WX. Development of a simplified scoring system for MRI-detected retropharyngeal lymph node features to optimize AJCC 9th edition N classification in nasopharyngeal carcinoma. Oral Oncol. 2026 Feb; 173:107825.
    View in: PubMed
    Score: 0.013
  21. He SQ, Huang Y, Zhao ZY, Wen SQ, Lv SH, Wang L, Bei WX, Xiang YQ, Liu GY. Capecitabine combined with immunotherapy as maintenance therapy improves survival in recurrent/metastatic nasopharyngeal carcinoma: a retrospective cohort study. Br J Cancer. 2026 Feb; 134(4):598-607.
    View in: PubMed
    Score: 0.013
  22. He SQ, Lv SH, Wen SQ, Wang L, Yu YH, Zhang GY, Peng DS, Bei WX, Chen CL, Zhao ZY, Huang Y, Xiang YQ, Liu GY. Efficacy of metastasis-directed therapy in de novo metastatic nasopharyngeal carcinoma patients receiving chemo-immunotherapy and local regional radiotherapy: a multicenter retrospective study. BMC Cancer. 2025 Dec 02; 25(1):1847.
    View in: PubMed
    Score: 0.013
  23. Gao Y, Du C, Xu Y, Cheng X, Zhao H, Jiang F, Cheng N, Xiang Y, Zhang Y, Li Y, Liu H, Chai X, Lian X, Zhao W, Li N. Optimal Levothyroxine Dosing Strategy for Immune Checkpoint Inhibitor-related Hypothyroidism: A Retrospective Study. J Clin Endocrinol Metab. 2025 Nov 18; 110(12):3342-3353.
    View in: PubMed
    Score: 0.013
  24. He SQ, Lv SH, Wen SQ, Yu YH, Zhang GY, Peng DS, Bei WX, Chen CL, Zhao ZY, Huang Y, Xiang YQ, Liu GY. Efficacy of metastatic lesion radiotherapy in de novo metastatic nasopharyngeal carcinoma patients receiving local regional radiotherapy and chemo-immunotherapy: a multicenter retrospective study. Radiother Oncol. 2025 12; 213:111160.
    View in: PubMed
    Score: 0.013
  25. Xu C, Liang XY, Huang XQ, Jin F, Yang KY, Hu GY, Zhu XD, Wang Y, Huang Y, Zhang N, Hu DS, Guo L, Zou GR, Chen XZ, Xiao SW, Li JG, Shen LF, Li YY, Huang J, Long GX, Li L, Huang L, She LJ, Wu Y, Zeng WH, Qiang MY, Liu WX, Su Y, Tang LL, Xie FY, Han F, Lu LX, Xiang YQ, Mao YP, Li WF, Liu X, Yang Q, Zhou GQ, Guo R, Ouyang PY, Wang XH, Chen L, Liu LT, Lin L, Li JB, Lin AH, Zhao HY, Hong SB, Jie YS, Huang HL, Tang XH, Zeng YC, Yun JP, Zang SB, Du ZM, Ye ZL, Liu LZ, Tian L, Li HJ, Peng YL, Liu N, Li YQ, Liang YL, Wei HM, Chen YP, Zhang Y, Du XJ, Lv JW, Sun Y, Ma J. Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma: The DIAMOND Randomized Clinical Trial. JAMA. 2025 Sep 16; 334(11):973-983.
    View in: PubMed
    Score: 0.013
  26. Guo SS, Li XY, Liu LT, Jia GD, Liu SL, Sun XS, Luo DH, Yang JH, Xie SY, Li YF, Lv X, Xiang YQ, Xia WX, Sun R, Liu Q, Li JB, Wang P, Yang Q, Wang L, Wen DX, Jin J, Lin JY, Mo HY, Guo L, Zhao C, Guo X, Chen QY, Tang LQ, Mai HQ. Induction vs Adjuvant Chemoradiotherapy in Patients With High-Risk N2 to N3 Nasopharyngeal Carcinoma: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2025 Aug 01; 11(8):864-873.
    View in: PubMed
    Score: 0.013
  27. Bu XL, Zhu W, Wang QH, Liu ZT, Bao YY, Bai YD, Li JH, Liu ZH, Zhao JL, Xiang Y, Jin WS, Wang J, Lei X, Wang YJ. Association between self-reported multimorbidity and longitudinal brain A? deposition in Alzheimer's disease. Nat Commun. 2025 Jul 01; 16(1):5905.
    View in: PubMed
    Score: 0.013
  28. Randall L, Xiang Y, Matsumoto T, Giannarelli D, Milla DP, Lopez KA, Acevedo A, Vizkeleti J, Salani R, Nogueira-Rodrigues A, Mejia FC, Korach J, Akilli H, Lee JY, Saevets VV, Samouelian V, Sehouli J, Tharavichikul E, Sukhin V, Colombo N, Chang CL, Cueva JF, Lalondrelle S, Petru E, Szamreta E, Nguyen AM, Yamada K, Li K, Pignata S, Lorusso D. Patient-reported outcomes from the phase 3, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 study of pembrolizumab plus concurrent chemoradiotherapy in participants with high-risk locally advanced cervical cancer. Gynecol Oncol. 2025 Aug; 199:88-95.
    View in: PubMed
    Score: 0.013
  29. Wu P, Song N, Xiang Y, Tao Z, Mao B, Guo R, Wang X, Wu D, Zhang Z, Chen X, Ma D, Zhang T, Hao B, Ma J. FOXK2 in skeletal muscle development: a new pathogenic gene for congenital myopathy with ptosis. EMBO Mol Med. 2025 Jul; 17(7):1599-1630.
    View in: PubMed
    Score: 0.012
  30. Li J, Xu J, Jin J, Xu C, Gan Y, Wang Y, Feng R, Fan W, Li Y, Zhao X, Li Y, Gong S, Su L, Cai Y, Shi L, Sun X, Xiang Y, Wang Q, Li R, Zhao J, Liu Y, Qin J, Li Z, He J. A Comprehensive Dataset on Microbiome Dynamics in Rheumatoid Arthritis from a Large-Scale Cohort Study. Sci Data. 2025 Feb 07; 12(1):232.
    View in: PubMed
    Score: 0.012
  31. Gui T, Cao D, Yang J, Wei Z, Xie J, Wang W, Xiang Y, Peng P. Early prediction and risk stratification of ovarian cancer based on clinical data using machine learning approaches. J Gynecol Oncol. 2025 07; 36(4):e53.
    View in: PubMed
    Score: 0.012
  32. Wang WX, Wu YS, Qi LP, Wu AMS, Zhu YY, Gong WJ, Guo SS, Hua YJ, Luo DH, Chen QY, Xiang YQ, Zhang JX, Mai HQ, Li JB. Prevalence of mental disorders and their associations with age at diagnosis and time since diagnosis of nasopharyngeal cancer. Front Public Health. 2024; 12:1469001.
    View in: PubMed
    Score: 0.012
  33. Qin L, Yao Y, Wang W, Qin Q, Liu J, Liu H, Yuan L, Yuan Y, Du X, Zhao B, Wu X, Qing B, Huang L, Wang G, Xiang Y, Qu X, Zhang X, Yang M, Xia Z, Liu C. Airway epithelial overexpressed cathepsin K induces airway remodelling through epithelial-mesenchymal trophic unit activation in asthma. Br J Pharmacol. 2024 Oct; 181(19):3700-3716.
    View in: PubMed
    Score: 0.012
  34. Li J, Xiong S, He P, Liang P, Li C, Zhong R, Cai X, Xie Z, Liu J, Cheng B, Chen Z, Liang H, Lao S, Chen Z, Shi J, Li F, Feng Y, Huo Z, Deng H, Yu Z, Wang H, Zhan S, Xiang Y, Wang H, Zheng Y, Lin X, He J, Liang W. Spatial whole exome sequencing reveals the genetic features of highly-aggressive components in lung adenocarcinoma. Neoplasia. 2024 08; 54:101013.
    View in: PubMed
    Score: 0.012
  35. Feng Y, Cheng B, Zhan S, Liu H, Li J, Chen P, Wang Z, Huang X, Fu X, Ye W, Wang R, Wang Q, Xiang Y, Wang H, Zhu F, Zheng X, Fu W, Hu G, Chen Z, He J, Liang W. The impact of PET/CT and brain MRI for metastasis detection among patients with clinical T1-category lung cancer: Findings from a large-scale cohort study. Eur J Nucl Med Mol Imaging. 2024 Sep; 51(11):3400-3416.
    View in: PubMed
    Score: 0.012
  36. Wang W, Kong Y, Li Y, Wan X, Feng F, Ren T, Zhao J, Xiang Y, Yang J. Pulmonary resection of residual lesions of pulmonary metastasis from gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2023 09 04; 33(9):1376-1382.
    View in: PubMed
    Score: 0.011
  37. Jiang F, Mao MY, Xiang Y, Lu X, Guan CL, Jiao LZ, Wan XR, Feng FZ, Ren T, Yang JJ, Zhao J. Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0-4): study protocol for a prospective, multicentre, randomized trial. BMC Cancer. 2023 Aug 23; 23(1):784.
    View in: PubMed
    Score: 0.011
  38. Gong X, Yuan S, Xiang Y, Fan L, Zhou H. Domain knowledge-guided adversarial adaptive fusion of hybrid breast ultrasound data. Comput Biol Med. 2023 09; 164:107256.
    View in: PubMed
    Score: 0.011
  39. Wang M, Chen X, Niu L, Xu J, Yu H, Xu X, Yang Q, Xiang Y, Le W. APPswe /PS1?E9 mice exhibit low oxygen saturation and alterations of erythrocytes preceding the neuropathology and cognitive deficiency during Alzheimer's disease. CNS Neurosci Ther. 2023 07; 29(7):1889-1897.
    View in: PubMed
    Score: 0.011
  40. Jiang F, Lin JK, Xiang Y, Xu ZF, Wan XR, Feng FZ, Ren T, Yang JJ, Zhao J. The impact of pulmonary metastases on therapeutic response and prognosis in malignant gestational trophoblastic neoplasia patients: a retrospective cohort study. Eur J Cancer. 2022 01; 161:119-127.
    View in: PubMed
    Score: 0.010
  41. Gao X, Yu H, Peng L, Gong X, Xiang Y, Jiang C, Zhou X. The mutuality of social emotions: How the victim's reactive attitude influences the transgressor's emotional responses. Neuroimage. 2021 12 01; 244:118631.
    View in: PubMed
    Score: 0.010
  42. Zheng H, Gao Y, Guo H, Li L, Li Q, Cui H, Lin A, Sun L, Hu Y, Kang S, Duan W, Pan L, Wang S, Yang Y, Li Y, Kong W, Xiang Y, Tian X, Ling B, Ha C, Bai W. Real-world Experience of Olaparib Treatment in Patients with Ovarian Cancer: A Chinese Multicenter Study. Mol Cancer Ther. 2021 09; 20(9):1735-1742.
    View in: PubMed
    Score: 0.010
  43. Lv X, Cao X, Xia WX, Liu KY, Qiang MY, Guo L, Qian CN, Cao KJ, Mo HY, Li XM, Li ZH, Han F, He YX, Liu YM, Wu SX, Bai YR, Ke LR, Qiu WZ, Liang H, Liu GY, Miao JJ, Li WZ, Lv SH, Chen X, Zhao C, Xiang YQ, Guo X. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial. Lancet Oncol. 2021 05; 22(5):716-726.
    View in: PubMed
    Score: 0.009
  44. Ding X, Wang J, Huang M, Chen Z, Liu J, Zhang Q, Zhang C, Xiang Y, Zen K, Li L. Loss of microglial SIRPa promotes synaptic pruning in preclinical models of neurodegeneration. Nat Commun. 2021 04 01; 12(1):2030.
    View in: PubMed
    Score: 0.009
  45. Yang J, Zhang H, Sun S, Wang X, Guan Y, Mi Q, Zeng W, Xiang H, Zhu H, Zou X, You Y, Xiang Y, Gao Q. Autophagy and Hsp70 activation alleviate oral epithelial cell death induced by food-derived hypertonicity. Cell Stress Chaperones. 2020 03; 25(2):253-264.
    View in: PubMed
    Score: 0.009
  46. Ran Q, Jin F, Xiang Y, Xiang L, Wang Q, Li F, Chen L, Zhang Y, Wu C, Zhou L, Xiao Y, Chen L, Wu J, Zhong JF, Li SC, Li Z. CRIF1 as a potential target to improve the radiosensitivity of osteosarcoma. Proc Natl Acad Sci U S A. 2019 10 08; 116(41):20511-20516.
    View in: PubMed
    Score: 0.008
  47. Yang Q, Cao SM, Guo L, Hua YJ, Huang PY, Zhang XL, Lin M, You R, Zou X, Liu YP, Xie YL, Wang ZQ, Mai HQ, Chen QY, Tang LQ, Mo HY, Cao KJ, Qian CN, Zhao C, Xiang YQ, Zhang XP, Lin ZX, Li WX, Liu Q, Li JB, Ling L, Guo X, Hong MH, Chen MY. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial. Eur J Cancer. 2019 09; 119:87-96.
    View in: PubMed
    Score: 0.008
  48. Li YM, Peng C, Zhang JG, Zhu W, Xu C, Lin Y, Fu XY, Tian Q, Zhang L, Xiang Y, Sheng V, Deng HW. Genetic risk factors identified in populations of European descent do not improve the prediction of osteoporotic fracture and bone mineral density in Chinese populations. Sci Rep. 2019 04 15; 9(1):6086.
    View in: PubMed
    Score: 0.008
  49. Liu GY, Lv X, Wu YS, Mao MJ, Ye YF, Yu YH, Liang H, Yang J, Ke LR, Qiu WZ, Huang XJ, Li WZ, Guo X, Xiang YQ, Xia WX. Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis. Cancer Commun (Lond). 2018 05 10; 38(1):21.
    View in: PubMed
    Score: 0.008
  50. Tang LQ, Chen DP, Guo L, Mo HY, Huang Y, Guo SS, Qi B, Tang QN, Wang P, Li XY, Li JB, Liu Q, Gao YH, Xie FY, Liu LT, Li Y, Liu SL, Xie HJ, Liang YJ, Sun XS, Yan JJ, Wu YS, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Lv X, Wang L, Xia WX, Zhao C, Cao KJ, Qian CN, Guo X, Hong MH, Nie ZQ, Chen QY, Mai HQ. Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol. 2018 04; 19(4):461-473.
    View in: PubMed
    Score: 0.008
  51. Zhao F, Lan X, Li T, Xiang Y, Zhao F, Zhang Y, Lee WH. Proteotranscriptomic Analysis and Discovery of the Profile and Diversity of Toxin-like Proteins in Centipede. Mol Cell Proteomics. 2018 04; 17(4):709-720.
    View in: PubMed
    Score: 0.007
  52. Qiu WZ, Ke LR, Xia WX, Yang J, Yu YH, Liang H, Huang XJ, Liu GY, Li WZ, Xiang YQ, Guo X, Lv X. A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapy. PLoS One. 2017; 12(8):e0182963.
    View in: PubMed
    Score: 0.007
  53. Xie P, Yang JP, Cao Y, Peng LX, Zheng LS, Sun R, Meng DF, Wang MY, Mei Y, Qiang YY, Cao L, Xiang YQ, Luo DH, Yun JP, Huang BJ, Jia LJ, Qian CN. Promoting tumorigenesis in nasopharyngeal carcinoma, NEDD8 serves as a potential theranostic target. Cell Death Dis. 2017 06 01; 8(6):e2834.
    View in: PubMed
    Score: 0.007
  54. Yu S, Liu YP, Liu HL, Li J, Xiang Y, Liu YH, Jiao SS, Liu L, Wang Y, Fu W. Serum Protein-Based Profiles as Novel Biomarkers for the Diagnosis of Alzheimer's Disease. Mol Neurobiol. 2018 May; 55(5):3999-4008.
    View in: PubMed
    Score: 0.007
  55. Ke LR, Xia WX, Qiu WZ, Huang XJ, Yu YH, Liang H, Liu GY, Xiang YQ, Guo X, Lv X. A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinoma. Oral Oncol. 2017 07; 70:7-13.
    View in: PubMed
    Score: 0.007
  56. Cao SM, Yang Q, Guo L, Mai HQ, Mo HY, Cao KJ, Qian CN, Zhao C, Xiang YQ, Zhang XP, Lin ZX, Li WX, Liu Q, Qiu F, Sun R, Chen QY, Huang PY, Luo DH, Hua YJ, Wu YS, Lv X, Wang L, Xia WX, Tang LQ, Ye YF, Chen MY, Guo X, Hong MH. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase III multicentre randomised controlled trial. Eur J Cancer. 2017 04; 75:14-23.
    View in: PubMed
    Score: 0.007
  57. Liang H, Xiang YQ, Lv X, Xie CQ, Cao SM, Wang L, Qian CN, Yang J, Ye YF, Gan F, Ke LR, Yu YH, Liu GY, Qiu WZ, Huang XJ, Wen CH, You N, Wang XQ, Guo X, Xia WX. Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area. Eur J Cancer. 2017 03; 73:48-60.
    View in: PubMed
    Score: 0.007
  58. Guntur AR, Gou B, Gu P, He R, Stern U, Xiang Y, Yang CH. H2O2-Sensitive Isoforms of Drosophila melanogaster TRPA1 Act in Bitter-Sensing Gustatory Neurons to Promote Avoidance of UV During Egg-Laying. Genetics. 2017 02; 205(2):749-759.
    View in: PubMed
    Score: 0.007
  59. Zeng Q, Wang J, Lv X, Li J, Yin LJ, Xiang YQ, Guo X. Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis. BMC Cancer. 2016 08 30; 16:693.
    View in: PubMed
    Score: 0.007
  60. Guo SS, Tang LQ, Chen QY, Zhang L, Liu LT, Guo L, Mo HY, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Wang L, Lv X, Zhao C, Guo X, Cao KJ, Qian CN, Zeng MS, Bei JX, Hong MH, Shao JY, Sun Y, Ma J, Mai HQ. Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA =4000 copies/ml: a matched study. Oncotarget. 2016 May 17; 7(20):29739-48.
    View in: PubMed
    Score: 0.007
  61. Gao X, Gong P, Liu J, Hu J, Li Y, Yu H, Gong X, Xiang Y, Jiang C, Zhou X. COMT Val158Met polymorphism influences the susceptibility to framing in decision-making: OFC-amygdala functional connectivity as a mediator. Hum Brain Mapp. 2016 May; 37(5):1880-92.
    View in: PubMed
    Score: 0.007
  62. Wu X, Zhang Y, Takle K, Bilsel O, Li Z, Lee H, Zhang Z, Li D, Fan W, Duan C, Chan EM, Lois C, Xiang Y, Han G. Dye-Sensitized Core/Active Shell Upconversion Nanoparticles for Optogenetics and Bioimaging Applications. ACS Nano. 2016 Jan 26; 10(1):1060-6.
    View in: PubMed
    Score: 0.007
  63. Guo SS, Tang LQ, Zhang L, Chen QY, Liu LT, Guo L, Mo HY, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Wang L, Lv X, Zhao C, Guo X, Cao KJ, Qian CN, Zeng MS, Bei JX, Hong MH, Shao JY, Sun Y, Ma J, Mai HQ. The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy. BMC Cancer. 2015 Dec 16; 15:977.
    View in: PubMed
    Score: 0.006
  64. Tang LQ, Li CF, Li J, Chen WH, Chen QY, Yuan LX, Lai XP, He Y, Xu YX, Hu DP, Wen SH, Peng YT, Zhang L, Guo SS, Liu LT, Guo L, Wu YS, Luo DH, Huang PY, Mo HY, Xiang YQ, Sun R, Chen MY, Hua YJ, Lv X, Wang L, Zhao C, Cao KJ, Qian CN, Guo X, Zeng YX, Mai HQ, Zeng MS. Establishment and Validation of Prognostic Nomograms for Endemic Nasopharyngeal Carcinoma. J Natl Cancer Inst. 2016 Jan; 108(1).
    View in: PubMed
    Score: 0.006
  65. Wang L, Yu H, Hu J, Theeuwes J, Gong X, Xiang Y, Jiang C, Zhou X. Reward breaks through center-surround inhibition via anterior insula. Hum Brain Mapp. 2015 Dec; 36(12):5233-51.
    View in: PubMed
    Score: 0.006
  66. Ye YF, Xiang YQ, Fang F, Gao R, Zhang LF, Xie SH, Liu Z, Du JL, Chen SH, Hong MH, Qian CN, Ye W, Zeng YX, Liu Q, Cao SM. Hepatitis B virus infection and risk of nasopharyngeal carcinoma in southern China. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1766-73.
    View in: PubMed
    Score: 0.006
  67. Qin L, Yin YT, Zheng FJ, Peng LX, Yang CF, Bao YN, Liang YY, Li XJ, Xiang YQ, Sun R, Li AH, Zou RH, Pei XQ, Huang BJ, Kang TB, Liao DF, Zeng YX, Williams BO, Qian CN. WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis. Oncotarget. 2015 Apr 30; 6(12):10239-52.
    View in: PubMed
    Score: 0.006
  68. Qiu Q, Xiong W, Yang C, Dai X, Dan X, Yang Z, Jiao Y, Xiang Y, Liu G, Hardy P. Lymphocyte-derived microparticles induce apoptosis of airway epithelial cells through activation of p38 MAPK and production of arachidonic acid. Apoptosis. 2014 Jul; 19(7):1113-27.
    View in: PubMed
    Score: 0.006
  69. Li SA, Xiang Y, Wang YJ, Liu J, Lee WH, Zhang Y. Naturally occurring antimicrobial peptide OH-CATH30 selectively regulates the innate immune response to protect against sepsis. J Med Chem. 2013 Nov 27; 56(22):9136-45.
    View in: PubMed
    Score: 0.006
  70. Huang PY, Cao KJ, Guo X, Mo HY, Guo L, Xiang YQ, Deng MQ, Qiu F, Cao SM, Guo Y, Zhang L, Li NW, Sun R, Chen QY, Luo DH, Hua YJ, Mai HQ, Hong MH. A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma. Oral Oncol. 2012 Oct; 48(10):1038-1044.
    View in: PubMed
    Score: 0.005
  71. Yang CH, Rumpf S, Xiang Y, Gordon MD, Song W, Jan LY, Jan YN. Control of the postmating behavioral switch in Drosophila females by internal sensory neurons. Neuron. 2009 Feb 26; 61(4):519-26.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.